These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33663674)

  • 1. [Research Progress of Adipokine and Kidney Disease].
    Zhang RX; Zhang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):130-135. PubMed ID: 33663674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
    Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.
    Tsiotra PC; Halvatsiotis P; Patsouras K; Maratou E; Salamalekis G; Raptis SA; Dimitriadis G; Boutati E
    Peptides; 2018 Mar; 101():157-166. PubMed ID: 29337272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of omentin and chemerin in metabolic syndrome and tumor diseases.
    Szydło B; Kiczmer P; Świętochowska E; Ostrowska Z
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):844-9. PubMed ID: 27516571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
    Gualillo O; González-Juanatey JR; Lago F
    Trends Cardiovasc Med; 2007 Nov; 17(8):275-83. PubMed ID: 18021938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue dysfunction in nascent metabolic syndrome.
    Bremer AA; Jialal I
    J Obes; 2013; 2013():393192. PubMed ID: 23653857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
    Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
    J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemerin: a multifaceted adipokine involved in metabolic disorders.
    Helfer G; Wu QF
    J Endocrinol; 2018 Aug; 238(2):R79-R94. PubMed ID: 29848608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease.
    Schrover IM; van der Graaf Y; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2018 Sep; 25(14):1548-1557. PubMed ID: 30052066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adipokines in the pathogenesis of gestational diabetes mellitus.
    de Gennaro G; Palla G; Battini L; Simoncini T; Del Prato S; Bertolotto A; Bianchi C
    Gynecol Endocrinol; 2019 Sep; 35(9):737-751. PubMed ID: 30990092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
    Pan BL; Ma RM
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1231-1236. PubMed ID: 27687656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases.
    Recinella L; Orlando G; Ferrante C; Chiavaroli A; Brunetti L; Leone S
    Front Physiol; 2020; 11():578966. PubMed ID: 33192583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipobiology for novel therapeutic approaches in metabolic syndrome.
    Malagón MM; Díaz-Ruiz A; Guzmán-Ruiz R; Jiménez-Gómez Y; Moreno NR; García-Navarro S; Vázquez-Martínez R; Peinado JR
    Curr Vasc Pharmacol; 2013 Nov; 11(6):954-67. PubMed ID: 24168446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do novel adipokines play a causative or only modulating role in the pathogenesis of obesity and metabolic disorders?
    Kalisz M; Baranowska B; Bik W
    Neuro Endocrinol Lett; 2012; 33(1):11-5. PubMed ID: 22467105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chemerin in human disease.
    Stojek M
    Postepy Hig Med Dosw (Online); 2017 Feb; 71(0):110-117. PubMed ID: 28258671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity.
    Ramanjaneya M; Chen J; Brown JE; Tripathi G; Hallschmid M; Patel S; Kern W; Hillhouse EW; Lehnert H; Tan BK; Randeva HS
    Endocrinology; 2010 Jul; 151(7):3169-80. PubMed ID: 20427481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of omentin as a pleiotropic adipocytokine.
    Jaikanth C; Gurumurthy P; Cherian KM; Indhumathi T
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):377-83. PubMed ID: 23839538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
    Motawi TMK; Mahdy SG; El-Sawalhi MM; Ali EN; El-Telbany RFA
    Can J Physiol Pharmacol; 2018 Jan; 96(1):38-44. PubMed ID: 28957639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue, obesity and adipokines: role in cancer promotion.
    Booth A; Magnuson A; Fouts J; Foster M
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):57-74. PubMed ID: 25781552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.